Novel endothelin antagonists claimed for cardiovascular, cerebrovascular and other disorders Nov. 6, 1998
Ribozyme oligonucleotides against apo(a) as novel therapeutic strategy for cardiovascular diseases Nov. 5, 1998
Suntory describes new series for cardio- and cerebrovascular and peripheral circulatory disorders Nov. 3, 1998
Cardioprotective effects of carvedilol metabolite are less potent than those of the parent drug Nov. 3, 1998
Continuing efforts at Parke-Davis result in structurally novel functional ETA receptor antagonist Nov. 2, 1998
RSS